Financial results - TILIAE PHARMA S.R.L.

Financial Summary - Tiliae Pharma S.r.l.
Unique identification code: 7258342
Registration number: J04/466/1995
Nace: 4773
Sales - Ron
213.031
Net Profit - Ron
15.885
Employees
1
Open Account
Company Tiliae Pharma S.r.l. with Fiscal Code 7258342 recorded a turnover of 2024 of 213.031, with a net profit of 15.885 and having an average number of employees of 1. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Tiliae Pharma S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 183.730 210.749 216.380 223.771 214.201 187.725 172.563 177.612 204.671 213.031
Total Income - EUR 183.732 213.282 217.064 223.784 214.204 188.160 172.564 179.815 213.407 221.483
Total Expenses - EUR 170.841 192.856 191.858 192.444 190.111 169.761 158.229 163.311 192.952 202.573
Gross Profit/Loss - EUR 12.891 20.426 25.206 31.340 24.093 18.399 14.335 16.503 20.455 18.911
Net Profit/Loss - EUR 10.719 16.920 22.884 29.081 22.029 16.988 12.851 14.966 18.319 15.885
Employees 2 3 2 2 1 1 0 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 4.7%, from 204.671 euro in the year 2023, to 213.031 euro in 2024. The Net Profit decreased by -2.331 euro, from 18.319 euro in 2023, to 15.885 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Tiliae Pharma S.r.l.

Rating financiar

Financial Rating -
TILIAE PHARMA S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Tiliae Pharma S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Tiliae Pharma S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Tiliae Pharma S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Tiliae Pharma S.r.l. - CUI 7258342

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 69.133 60.584 57.930 55.267 52.628 50.610 47.693 63.847 57.728 53.026
Current Assets 39.817 36.068 46.334 50.453 45.635 53.600 57.255 49.259 60.335 63.521
Inventories 27.669 29.081 30.417 30.977 32.240 31.815 31.940 34.143 44.303 43.696
Receivables 11.011 778 14.840 17.586 12.445 14.788 11.824 13.548 12.586 9.700
Cash 1.137 6.209 1.077 1.890 950 6.998 13.491 1.567 3.446 10.124
Shareholders Funds 63.220 68.886 73.971 79.230 71.206 65.233 60.026 62.288 80.417 62.800
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 45.730 27.767 30.293 26.490 27.056 38.977 44.922 48.689 36.054 52.692
Income in Advance 0 0 0 0 0 0 0 2.129 1.592 1.055
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 63.521 euro in 2024 which includes Inventories of 43.696 euro, Receivables of 9.700 euro and cash availability of 10.124 euro.
The company's Equity was valued at 62.800 euro, while total Liabilities amounted to 52.692 euro. Equity decreased by -17.168 euro, from 80.417 euro in 2023, to 62.800 in 2024. The Debt Ratio was 45.2% in the year 2024.

Risk Reports Prices

Reviews - Tiliae Pharma S.r.l.

Comments - Tiliae Pharma S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.